Trials / Unknown
UnknownNCT00899483
Can Enhanced Glycemic Control in Type II Diabetics Improve Myocardial Protection During Coronary Artery Bypass Grafting?
Can Enhanced Glycaemic Control in Type II Diabetics Improve Myocardial Protection During Coronary Artery Bypass Grafting?
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- University Hospital Birmingham · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The investigators have previously demonstrated that the administration of insulin in the form of an infusion with additional sugar and potassium may improve cardiovascular performance and reduce biochemical evidence of heart muscle injury in non-diabetic patients undergoing coronary artery surgery. The investigators now seek to demonstrate that similar benefits can be achieved in diabetic patients by administering insulin to maintain as near absolutely normal sugar levels as possible.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glucose potassium insulin solution | Enhanced glycaemic control in diabetics with glucose-potassium-insulin solution |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2012-07-01
- First posted
- 2009-05-12
- Last updated
- 2009-05-12
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00899483. Inclusion in this directory is not an endorsement.